The historical rank and industry rank for Indoco Remedies's FCF Margin % or its related term are showing as below:
NSE:INDOCO'
s FCF Margin % Range Over the Past 10 Years
Min: -15.13 Med: -0.6 Max: 5.96
Current: 5.64
During the past 13 years, the highest FCF Margin % of Indoco Remedies was 5.96%. The lowest was -15.13%. And the median was -0.60%.
NSE:INDOCO's FCF Margin % is ranked better than 58.22% of 955
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs NSE:INDOCO: 5.64
Indoco Remedies FCF Margin % Related Terms
Indoco Remedies FCF Margin % Historical Data
* Premium members only.
The historical data trend for Indoco Remedies's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indoco Remedies FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Indoco Remedies's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indoco Remedies (NSE:INDOCO) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Indoco Remedies and its competitors. According to the industry distribution chart, Indoco Remedies ranks #399 out of 955 companies in the Drug Manufacturers industry, placing it in the top 41.8%.
Is Indoco Remedies' FCF Margin % too high?
Indoco Remedies' current FCF Margin % is 0.00%. Based on the distribution chart, Indoco Remedies ranks #399 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Indoco Remedies has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Indoco Remedies ranks #399 out of 955 companies for FCF Margin %. This puts Indoco Remedies in the upper half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Indoco Remedies and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indoco Remedies's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (NSE:INDOCO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹358.97, compared to a current price of ₹231.60 — trading 35.5% below its estimated fair value. The current FCF Margin % is 0.00%. Indoco Remedies' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Indoco Remedies (NSE:INDOCO), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?
Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued.
The current stock price of ₹231.60 is trading 35.5% below its estimated GF Value™ of ₹358.97.
GuruFocus considers Indoco Remedies to be Possible Value Trap.
Key valuation signals for NSE:INDOCO:
FCF Margin %: 0.00%
GF Value™: ₹358.97 vs. price of ₹231.60 (35.5% below fair value)
No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
66GF Score
Get the complete analysis for NSE:INDOCO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOCO has been successfully added to your 
